Personal Trainer

Parkwood Leisure begins offering Bupa's health subscription service. * Posted on April 21, 2026 Integrating Bupa Well+ is part of Parkwood's strategy to position itself beyond the traditional gym model (Image: Parkwood Leisure) Parkwood Leisure has partnered with health services provider Bupa to offer members access to Bupa's Well+ health subscriptions as part of its premium membership packages. The deal will allow Parkwood members to complement their fitness routines with additional tools to support their wider health and wellbeing. Bupa Well+ provides access to a range of digital health services, including GP appointments, physiotherapy, mental health support and diet and nutritional advice. Integrating Bupa Well+ is part of Parkwood's strategy to position itself beyond the traditional gym model by providing a 360-degree approach to wellness - encompassing physical activity, mental health support and preventative care. The partnership will begin at select pilot sites in May 2026, allowing for a tailored implementation process. Following the initial phase, the offer will be rolled out across all Parkwood sites nationwide starting in June or July 2026. Andy Farr, Strategic Director at Parkwood Leisure, said: "Well Nation is incredibly excited to partner with a globally renowned brand like Bupa. "Our mission has always been to support the health of the communities we serve, but this partnership allows us to go further. By integrating Well+ into our offer, we are bridging the gap between fitness and clinical healthcare, providing our members with the tools they need to thrive both inside and outside our centres." Parkwood Leisure manages 76 facilities on behalf of 42 local authorities throughout England and Wales.

Bupa appoints Philip Broadley, Bruno Holthof and Gill Whitehead as Non-Executive Directors. 31 March 2026 Bupa today announces the appointments of Philip Broadley as a Non-Executive Director with effect from 1 April 2026 and Professor Bruno Holthof and Gill Whitehead, OBE as Non-Executive Directors from 10 April 2026. Philip will join the Audit, Risk and Remuneration Committees, Bruno will join the Remuneration Committee and Gill will join the Risk Committee. All three will also join the Nomination & Governance Committee. Philip brings extensive international life sciences and financial services experience having worked in both senior executive and non-executive board roles in four FTSE100 listed companies. Previously he was Group Finance Director of Prudential plc from 2000 until 2008 and subsequently held the same position at Old Mutual plc from 2008 until 2014. He has served as Chairman of 100 Group of Finance Directors and as a member of the Code Committee of The Takeover Panel. He was a director of Legal & General Group plc from 2016 until 2025, chairing the audit committee for six years and serving for a time as Senior Independent Director. Prior to his board roles, Mr. Broadley began his career at Arthur Andersen in 1983, becoming a partner in 1993, where he specialised in auditing banks and insurance companies. Mr. Broadley is a Fellow of the Institute of Chartered Accountants in England and Wales. Mr. Broadley graduated in Philosophy, Politics and Economics from St. Edmund Hall, Oxford, where he is now a St. Edmund Fellow. He holds an MSc in Behavioural Science from the London School of Economics. Philip is Chair of Lancashire Holdings Limited and Senior Independent Director and Audit Committee Chair at AstraZeneca PLC. Bruno brings in-depth knowledge of healthcare systems in different markets, with an operational understanding of healthcare services and more than 10 years' experience on the boards of public listed companies. He has previously served as CEO of Oxford University Hospitals NHS Foundation Trust (2015-2022) and CEO of the Antwerp Hospital Network (2004-2015). Prior to that he was a partner at McKinsey & Company, serving a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven. He is Investment Partner of the EQT Life Sciences Health Economics Funds and Visiting Professor of Health Innovation at the University of Oxford. Non-Executive Chair of Financière de Tubize, reference shareholder of UCB, a global biopharma company and Non-Executive Chair of Tristel plc, an AIM listed company providing innovative disinfection solutions to hospitals worldwide. Gill brings significant executive and regulatory experience in the technology and media sectors having worked at Ofcom, Google, Channel 4 and the BBC. She is a Visiting Policy Fellow at the University of Oxford's Internet Institute focusing on global developments in AI safety, and is a Responsible AI advisory panel member to UK Government Digital Services. Gill was Group Director, Online Safety at Ofcom until late 2024 and Chair of the Global Online Safety Regulator Network for 2024. Before that, from 2021 to early 2023, she was Chief Executive of the Digital Regulators Forum, a collaboration between the UK's largest regulators. Gill spent four years as a Senior Director at Google, leading Market Insights and Client Solutions & Analytics teams, after holding several digital strategy and data leadership roles at Channel 4 and the BBC. She began her career at Deloitte Consulting. Gill's Board experience spans FTSE 50 companies, public bodies and sport. She has previously served as a Non-Executive Director of the Financial Ombudsman Service and Camelot (operator of the UK National Lottery). She is currently a Non-Executive Director at NatWest Group plc, Informa plc, the British Olympic Association, and was Chair of the Women's Rugby World Cup (England) 2025. She received an OBE in the 2026 King's New Year Honours for services to women's rugby. Don Robert, CBE, Bupa Board Chair, said: "We are delighted to welcome Philip, Bruno and Gill to the Bupa Board. Their appointments will strengthen the financial services, clinical and digital experience on the Board at an important time in Bupa's strategic development, and I look forward to working with them all." The British United Provident Association Limited (BUPA 1025Z LN) About Bupa. Established in 1947, Bupa's purpose is helping people live longer, healthier, happier lives and making a better world. Bupa is an international healthcare company serving 68 million customers worldwide. With no shareholders, Bupa reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. Bupa also have associate businesses in Saudi Arabia.